Literature DB >> 2527895

Pharmacotherapy of depressive disorders. A consensus statement. WHO Mental Health Collaborating Centres.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2527895

Source DB:  PubMed          Journal:  J Affect Disord        ISSN： 0165-0327            Impact factor:   4.839


× No keyword cloud information.
  10 in total

1.  Current issues in the economics of depression management.

Authors:  D Thompson; E Richardson
Journal:  Curr Psychiatry Rep       Date:  1999-12       Impact factor: 5.285

Review 2.  Managing selective serotonin reuptake inhibitor-drug interactions in clinical practice.

Authors:  J R Rosenbaum
Journal:  Clin Pharmacokinet       Date:  1995       Impact factor: 6.447

Review 3.  Selective serotonin reuptake inhibitors. Assessment for formulary inclusion.

Authors:  B H Guze
Journal:  Pharmacoeconomics       Date:  1996-05       Impact factor: 4.981

4.  A Markov process analysis comparing the cost effectiveness of maintenance therapy with citalopram versus standard therapy in major depression.

Authors:  M J Nuijten; M Hardens; E Souêtre
Journal:  Pharmacoeconomics       Date:  1995-08       Impact factor: 4.981

Review 5.  Fluoxetine. A pharmacoeconomic review of its use in depression.

Authors:  M I Wilde; P Benfield
Journal:  Pharmacoeconomics       Date:  1998-05       Impact factor: 4.981

6.  Cost effectiveness of fluvoxamine in the treatment of recurrent depression in France.

Authors:  M Nuijten; L Hadjadjeba; C Evans; J van den Berg
Journal:  Pharmacoeconomics       Date:  1998-10       Impact factor: 4.981

Review 7.  Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness.

Authors:  M G Harris; P Benfield
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

Review 8.  Lithium. Current status in psychiatric disorders.

Authors:  M Peet; J P Pratt
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

9.  Multiple depression : making mood manageable.

Authors:  Ilpo Helén
Journal:  J Med Humanit       Date:  2007-09

10.  A Comparative Study on Safety and Efficacy of Desvenlafaxine Versus Sertraline in Depression.

Authors:  Saritha Ch; Sree Sudha; C Gowtham Reddy; Pugazhenthan T; Krishna Sasanka Ksbs; Pooja Dasari; Pradeep Battula; Nandini T; Sandeep A
Journal:  Cureus       Date:  2022-02-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.